Vascular Ehlers-Danlos syndrome (VEDS) is an inherited disorder of connective tissue characterized by abnormalities in collagen structure that lead to increased fragility of blood vessels, often resulting in serious vascular complications. Patients with this syndrome may experience multiple vascular ruptures, which is the leading cause of early mortality in this group. It is important to note that this syndrome has many similarities with other forms of Ehlers-Danlos, but its clinical presentation and genetic mechanisms are different. One of the peculiarities of VEDS is that the disease can manifest itself at an early age, and serious vascular events can occur even with physical activity that is considered insignificant for healthy people.
History of the disease and interesting historical facts
Ehlers-Danlos syndrome was first described in 1901 by two dermatologists, Ehlers and Danlos, but the vascular form was identified later, mainly due to clinical observations and molecular studies. For many years, the disease remained little known in medical practice, and it was first defined as a separate clinical entity in 1986. Interestingly, in some cases, VEDS was detected post factum, for example, at autopsy, when analyzing the causes of sudden cardiac death in young patients. In recent decades, many studies have been conducted on the genetic mechanisms predisposing to the development of VEDS, which have opened new horizons in understanding this disease and its pathogenesis.
Epidemiology
The lack of precise data on the prevalence of vascular Ehlers-Danlos syndrome makes it difficult to estimate the true scale of the problem. Overall, the prevalence of VEDS is approximately 1 in 50,000 to 1 in 100,000 people. Research suggests that women are more likely to be affected than men, due to differences in genetic transmission and clinical manifestations of the disease. The highest number of reported cases occurs in areas with high levels of medical care and genetic counseling, which may lead to increased diagnosis and reporting of the disease.
Genetic predisposition to this disease
Vascular Ehlers-Danlos syndrome is caused by mutations in genes involved in collagen synthesis. In particular, the main genes involved in the pathogenesis of VEDS are COL3A1 and COL1A1. Mutations in COL3A1 lead to disruption of the structure of type III collagen, which is the main component of the vessel walls, and its deficiency creates a predisposition to ruptures. Identification of these genetic changes is possible using molecular genetic research methods such as exome sequencing or targeted genetic testing.
Risk factors for the development of this disease
Although VEDS is primarily a hereditary disorder, there are some risk factors that may make the disease worse:
- Physical activity: Intense physical activity can trigger vascular events.
- Trauma: Any trauma, even minor, can lead to ruptured blood vessels.
- Hormonal changes: Such as pregnancy, can increase the risk of rupture due to changes in the structure of blood vessels.
- Use of certain medications and chemicals that affect the condition of connective tissue.
These factors highlight the importance of caution regarding physical activity and injury in patients with VEDS and the need to monitor their condition.
Diagnosis of this disease
Diagnosis of vascular Ehlers-Danlos syndrome includes both clinical and laboratory methods:
- The main symptoms include:
- Unpredictable vascular ruptures
- Skin manifestations (joint hypermobility, fragile tissues)
- Cardiovascular disorders
- Laboratory tests may include specific tests to evaluate collagen structure.
- Radiological examinations such as MRI or ultrasound can help identify anatomical abnormalities of the vessels.
- Differential diagnosis should include other forms of Ehlers-Danlos syndrome and vascular diseases such as Marfan syndrome.
Treatment
Treatment of vascular Ehlers-Danlos syndrome is aimed at managing symptoms and preventing complications:
- General treatment includes caution when exercising and monitoring your health.
- Pharmacological treatment may include drugs to improve vascular strength and relieve pain, such as nonsteroidal anti-inflammatory drugs (NSAIDs).
- Surgical treatment may be necessary in case of vascular ruptures or other significant complications and should be performed with extreme caution.
- Other treatments may include physical therapy to support the joints and prevent hypermobility.
List of medications used to treat this disease
Medications used to treat VEDS may include:
- Nonsteroidal anti-inflammatory drugs (Ibuprofen, Naproxen);
- Drugs that enhance vascular strength (eg, high doses of ascorbic acid)
- Antibiotics for the prevention of infections during surgical interventions.
Disease monitoring
Monitoring of patients with VEDS is carried out on a regular basis and includes:
- Control stages for assessing the condition of blood vessels using ultrasound and other imaging methods.
- The prognosis depends on the severity of the disease and the presence of complications, but many patients can lead an active lifestyle with proper treatment.
- The presence of complications such as vascular ruptures requires immediate medical intervention, which emphasizes the importance of regular examinations and monitoring.
Age-related features of the disease
Vascular Ehlers-Danlos syndrome can manifest in different age groups. In newborns and children, symptoms may be less severe, while in adolescents and young adults, especially with physical activity, more serious vascular events are observed. In elderly patients, the course of the disease may be complicated by comorbidities such as atherosclerosis, which increases the risk of vascular rupture. Therefore, it is important to provide adapted treatment and monitoring depending on the patient's age.
Questions and Answers
- What is vascular Ehlers-Danlos syndrome?
Vascular Ehlers-Danlos syndrome is a hereditary connective tissue disorder characterized by increased vascular fragility and a predisposition to vascular rupture. - How is VEDS diagnosed?
Diagnosis of VEDS includes assessment of clinical symptoms, molecular genetic testing, and radiological methods to detect vascular abnormalities. - What treatment is indicated for VEDS?
Treatment may include careful exercise behavior, pharmacological treatment to improve vascular health, and surgery if complications occur. - What is the risk of complications with VEDS?
Complications such as vascular ruptures can occur in patients with VEDS, especially with physical activity, so monitoring them is very important. - How does VEDS manifest itself in different age groups?
Symptoms may vary across age groups: in children they may be less obvious, while in adolescents and adults vascular events may be more active.
This article demonstrates the importance of understanding vascular Ehlers-Danlos syndrome, as its signs and symptoms can vary significantly depending on the age and condition of the patient, highlighting the need for an individualized approach to treatment and monitoring.
